Ignite Creation Date:
2024-05-06 @ 1:57 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04173507
Status:
COMPLETED
Last Update Posted:
2024-06-04
First Post:
2019-11-20
Brief Title:
Combination Treatment Talazoparib Plus Avelumab for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation A LUNG-MAP Treatment Trial
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-20
First Submit QC Date:
November 20 2019
Study First Post Date:
2019-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-14
Last Update Post Date:
2024-06-04
Last Update Post Date Type:
ACTUAL